165 results
Page 3 of 9
8-K
EX-99.1
ovvnj8xisnoqlrhgj 2m
9 Nov 21
FibroGen Reports Third Quarter 2021 Financial Results
4:06pm
8-K
EX-99.1
ig2ynxud0ky h7w5
20 Aug 21
Other Events
12:00am
8-K
EX-99.1
pvz os7g2i3iu
16 Aug 21
FibroGen Announces Retirement of Pat Cotroneo and Appointment of Juan Graham as Chief Financial Officer
5:23pm
8-K
EX-99.1
0x7uaot23
11 Aug 21
FibroGen Receives Complete Response Letter from the FDA for Roxadustat for Anemia of Chronic Kidney Disease
8:30am
8-K
EX-99.1
sq30qdsnc ccfty0
9 Aug 21
FibroGen Reports Second Quarter 2021 Financial Results
4:05pm
8-K
EX-99.1
w87nyeggk9o2jub9y
25 Jun 21
Astellas Receives Positive CHMP Opinion for EVRENZOTM (roxadustat) for Adult Patients with Symptomatic Anemia of Chronic Kidney Disease
5:26pm
8-K
EX-99.1
43xx74o8
17 Jun 21
FibroGen and HiFiBiO Announce Transformative Partnership to
4:16pm
8-K
veot5n1ff6
14 May 21
Regulation FD Disclosure
5:22pm
8-K
EX-99.1
xoh3z
10 May 21
FibroGen Reports First Quarter 2021 Financial Results
4:07pm
8-K
EX-99.1
u39jlk
7 Apr 21
Regulation FD Disclosure
8:30am
8-K
EX-99.1
ru0x6
6 Apr 21
Company Continues to be Confident in the Benefit / Risk Profile of Roxadustat
4:59pm